Novo Holdings A/S’s Milestone Pharmaceuticals MIST Stock Holding History

Novo Holdings A/S’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,000,000	Closed	-$18.4M	–	51
2022 Q3	$18.4M	Sell	2,000,000 -530,003	-21%	-$4.02M	0.88%	24
2022 Q2	$15.6M	Hold	2,530,003	–	–	0.77%	23
2022 Q1	$16.2M	Sell	2,530,003 -582	-0%	-$3.64K	0.86%	22
2021 Q4	$16.6M	Hold	2,530,585	–	–	0.78%	25
2021 Q3	$14.4M	Hold	2,530,585	–	–	0.75%	27
2021 Q2	$13.9M	Hold	2,530,585	–	–	0.62%	30
2021 Q1	$14.7M	Hold	2,530,585	–	–	0.61%	29
2020 Q4	$17M	Buy	2,530,585 +450,000	+22%	+$3.01M	0.73%	27
2020 Q3	$15.2M	Hold	2,080,585	–	–	0.76%	21
2020 Q2	$7.87M	Hold	2,080,585	–	–	0.51%	26
2020 Q1	$3.83M	Sell	2,080,585 -353,885	-15%	-$6.13M	0.26%	26
2019 Q4	$39M	Sell	2,434,470 -240,000	-9%	-$4.25M	2.51%	8
2019 Q3	$49.9M	Hold	2,674,470	–	–	8.55%	4
2019 Q2	$72.6M	Buy	+2,674,470	New	+$55.1M	10.17%	2

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Novo Holdings A/S's MIST Position: Q4 2022 in Review

Novo Holdings A/S sold out of Milestone Pharmaceuticals (MIST) in Q4 2022, closing a stake of 2,000,000 shares — an estimated $18.4M sold.

Novo Holdings A/S first reported a position in MIST in Q2 2019 and held it in 14 quarters. The position peaked at $72.6M in Q2 2019. 56 funds tracked by Wall St. Rank hold MIST as of Q4 2022.

Novo Holdings A/S reported no remaining Milestone Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Novo Holdings A/S sold 2,000,000 Milestone Pharmaceuticals shares in Q4 2022, an estimated $18.4M.
Novo Holdings A/S first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 14 quarters.
Novo Holdings A/S's Milestone Pharmaceuticals position peaked at $72.6M in Q2 2019.
56 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2022.

Based on Novo Holdings A/S's 13F filing for Q4 2022, filed 14 Feb 2023.